Investigators
Top 5 Investigators in 2025
Dr Voon Pei Jye
Dr. Voon Pei Jye is an accomplished physician with extensive experience in oncology and clinical research. Currently serving as the Head of Department for the Radiotherapy and Oncology Department at Sarawak General Hospital in Kuching, he holds an M.D. from Universiti Malaysia Sarawak and MRCP from the Royal College of Physician, United Kingdom. Dr. Voon also holds a Master of Medicine and Advanced Specialist Training in Medical Oncology from the National University of Singapore and National Cancer Institute Singapore, as well as a Clinical Research Fellowship in Phase 1 Drug Development Program from Princess Margaret Cancer Centre, University Health Network, Toronto. Dr. Voon is an active clinical researcher and is currently overseeing numerous ongoing clinical trials. His research contributions have been recognized with numerous awards and honors. Additionally, he has published multiple manuscripts and presented abstracts and posters at various conferences. Dr. Voon is one of the scientific committee members of Asia Pacific Oncology Drug Development Consortium and also ATLAS Board. He is also a member of several professional committees and societies, including the Malaysian Oncological Society, European Society of Medical Oncology (ESMO), and American Society of Clinical Oncology (ASCO).
Dr Ang Choon Seong
Dr. Ang Choon Seong
Dr Diana Foo
Dr. Diana Foo
Dr Yusra Binti Hadi
Dr. Yusra Binti Hadi
Dr Law Wan Chung
Dr Law Wan Chung is a Consultant Neurologist and Head of Neurology Services in Sarawak, Malaysia. He has been an active and consistent contributor to clinical research, participating in numerous local and international studies and presenting his work at both national and international conferences. Dr Law is the Past President of the Malaysian Society of Neurosciences, Malaysia Chair for the ANGELS Initiative, Vice Chairman of the Malaysian Stroke Council, and an Adjunct Lecturer at Universiti Malaysia Sarawak (UNIMAS). His leadership and sustained commitment have played a key role in advancing neuroscience and stroke care at both national and regional levels.